Dr. Youmin Zhu | Innovative Leadership | Best Researcher Award

Dr. Youmin Zhu | Innovative Leadership | Best Researcher Award

Shanghai AZ Science and Technology Co., Ltd.

Author Profile

Orchid

🌱 Early Academic Pursuits

From the very beginning of his academic journey, Dr. Youmin Zhu demonstrated an exceptional passion for biological sciences. His intellectual curiosity led him to pursue a Ph.D. in biological sciences, where he laid a solid foundation in molecular biology, biotechnology, and pharmacology. During his doctoral years, he cultivated a deep interest in cutting-edge therapeutic strategies, particularly focusing on emerging protein degradation technologies and the role of bioactive peptides. His academic rigor and scientific curiosity propelled him to explore innovative modalities that bridged traditional research with real-world applications in drug and skincare development. These formative experiences not only enriched his technical skills but also instilled a vision to contribute meaningfully to both science and society.

🧪 Professional Endeavors

Now serving as the R&D President and Chief Scientist at Shanghai AZ Science and Technology Co., Ltd., Dr. Zhu has emerged as a visionary leader in the field of biotechnology. Under his guidance, the organization has completed over 20 major R&D projects, encompassing the development of peptide PROTACs-based skincare ingredients, enzymes, and probiotics. These endeavors reflect not only his scientific expertise but also his ability to translate theoretical concepts into commercial and therapeutic innovations.

Dr. Zhu’s strategic direction in the biotechnology sector has turned his company into a powerhouse of innovation, where the fusion of peptide-based therapeutics and skincare science is leading to transformative solutions. His work has bridged academic excellence with industrial application, enabling breakthroughs in precision medicine and advanced cosmeceuticals.

🔬 Contributions and Research Focus

Dr. Zhu’s research focus lies at the intersection of molecular biology, pharmacological innovation, and cosmetic science, with a central emphasis on peptide PROTACs (Proteolysis Targeting Chimeras). His pioneering efforts in this area have highlighted the multi-targeting potential of peptides, their biodegradability, low toxicity, and modular design, all of which present significant advantages over conventional small molecules and antibodies.

One of his most notable contributions is the publication of the article titled “The Peptide PROTAC Modality: A New Strategy for Drug Discovery” in MedComm (2025), an SCI-indexed journal with an impressive impact factor of 10.7. This work has been widely recognized in the scientific community and is already making waves in discussions around next-generation therapeutic strategies. The article has been cited across multiple domains, further demonstrating its relevance and value in ongoing pharmaceutical research.

With a total of over 10 scientific publications, Dr. Zhu has consistently contributed to scholarly literature and advanced dialogue in biotherapeutics. In addition, he holds 18 authorized patents in China, such as Patent No. CN202410445356.X, further underscoring his commitment to translating innovation into intellectual property and practical applications.

🏆 Accolades and Recognition

Dr. Zhu’s groundbreaking work has not gone unnoticed. His scientific and entrepreneurial achievements have earned him recognition within academic, industrial, and international circles. In addition to being a contributing scientist to impactful research, he has also been actively involved in collaborative projects with prestigious institutions including Fudan University, Shanghai Jiao Tong University, and Zhejiang University.

He is also an esteemed member of professional networks such as the Chinese Overseas Alliance and the Chinese Doctoral Alliance, where he continues to contribute to thought leadership and global knowledge exchange.

Furthermore, his work was recently highlighted in a widely circulated WeChat feature and an official PDF document of professional certification, showcasing his influence in both academic and industrial spheres.

🌍 Impact and Influence

Dr. Zhu’s influence extends beyond scientific circles. His work on peptide PROTACs is helping redefine how we understand and treat complex diseases. By leveraging the natural degradation mechanisms of the body through targeted proteolysis, his innovations are creating new avenues for the treatment of conditions previously considered untreatable.

Equally impressive is his impact on precision skincare, where bioengineered peptide-based compounds are providing customized, low-toxicity solutions for skin health. This cross-disciplinary impact, from health to beauty, positions Dr. Zhu as a transformative figure in the biotech and wellness industries.

His articles, particularly those involving collaborative authorship with Yu Dai and Yuncai Tian, have sparked global interest, and the citation of his MedComm article continues to grow. These ripple effects reflect the profound scientific and commercial value of his work.

🌟 Legacy and Future Contributions

As Dr. Zhu continues to push boundaries, the future of peptide-based therapeutics and cosmeceuticals looks increasingly promising. He is paving the way for a new era of precision medicine, where treatments are not only more effective but also safer and more sustainable.

Looking ahead, Dr. Zhu plans to scale his innovations globally and expand his company’s reach into international markets, bringing Chinese biotechnology to the global stage. His future goals include mentoring young scientists, fostering new academic-industry partnerships, and developing a global research ecosystem centered on peptide technologies.

Through his unwavering dedication and strategic foresight, Dr. Youmin Zhu is building a legacy that will inspire a generation of researchers and innovators. His contributions are not only advancing science but also shaping the future of healthcare and skincare for the better. 🌐

The Peptide PROTAC Modality: A New Strategy for Drug Discovery

Authors: Youmin Zhu, Yu Dai, Yuncai Tian
Journal: MedComm
Year: 2025

New Nobel Prize MicroRNA Technology Is Opening up a New Era of Precision Skincare

Authors: Youmin Zhu, Yu Dai, Xiaojing Wang, Shengjie Zhu, Yuncai Tian, Yong Tian
Journal: Advanced Journal of Nursing
Year: 2025

New peptide PROTAC is triggering a revolution in precise targeted skincare

Authors: Youmin Zhu, Yu Dai, Yuncai Tian, Yong Tian
Journal: Preprint (platform not specified)
Year: 2024

Advances in CRISPR/Cas9

Authors: Youmin Zhu, Syed Hassan
Journal: BioMed Research International
Year: 2022

Comparative Transcriptomics Reveals Jasmonic Acid-Associated Metabolism Related to Cotton Fiber Initiation

Authors: Liman Wang, Youmin Zhu, Wenjing Hu, Xueying Zhang, Caiping Cai, Wangzhen Guo
Journal: PLOS ONE
Year: 2015

Dr. Boris Arnaud Kouomogne Nteungue | Innovative Leadership | Best Researcher Award

Dr. Boris Arnaud Kouomogne Nteungue | Innovative Leadership | Best Researcher Award

Central University of Nicaragua, Cameroon

Profile 

Google Scholar

Early Academic Pursuits 📚

Boris Arnaud Kouomogne Nteungue’s academic journey began with an unwavering commitment to public health, which led him to pursue a Ph.D. in Public Health at the Central University of Nicaragua and Texila American University. Born in Cameroon and deeply aware of the health challenges his country faces, he directed his studies toward infectious disease prevention and control (IPC). His dedication to understanding the roots and repercussions of infectious diseases aligns with his objective to create meaningful change in public health. As a 34-year-old doctoral student, he has channeled his energy into research aimed at improving healthcare practices, policies, and outcomes, focusing particularly on infection prevention.

Professional Endeavors 🌍

Over the last decade, Boris’s professional path has been marked by influential roles and impactful initiatives. From 2021 to 2024, he served as an Infection Prevention and Control (IPC) Expert with the World Health Organization in Cameroon, where he was instrumental in responding to the COVID-19 pandemic. His work in the WHO included planning, implementing, and evaluating IPC strategies across various healthcare facilities, ensuring that healthcare workers were protected, and infectious spread was minimized. In addition, Boris held the critical role of General Coordinator of Nursing at Yaounde’s Emergency Center under the Ministry of Public Health in Cameroon. This role saw him oversee emergency nursing care, ensuring high standards and safe practices were adhered to during patient care. Through these experiences, Boris has become a recognized leader in public health and infection control, directly contributing to his community’s resilience in the face of health crises.

Contributions and Research Focus 🔬

Boris has made significant strides in research, particularly within the field of Infection Prevention and Control (IPC). His recent publications reflect his dedication to studying health challenges in crisis situations, focusing on the IPC measures in place during the COVID-19 pandemic in Cameroon. His work not only evaluated existing strategies but also contributed actionable insights by identifying barriers to effective IPC and recommending improvements based on the World Health Organization’s guidelines. Furthermore, Boris has extended his research to include baseline assessments of IPC in healthcare settings, laying the groundwork for continued advancements in infection prevention protocols.

His studies aim to provide evidence-based approaches that healthcare facilities can adopt to maintain hygiene and prevent infection transmission. One of his notable contributions was an evaluation of Cameroon’s national IPC strategy through a socio-ecological lens. This research identified structural and procedural barriers, suggesting sustainable interventions for the Ministry of Health to consider in developing a stronger national IPC framework. His multi-faceted research approach includes primary healthcare, emergency care, and road traffic accident care—areas he believes are pivotal to advancing public health standards in Cameroon and beyond.

Accolades and Recognition 🏆

Boris’s commitment to IPC and public health has been recognized on multiple levels. He has had two manuscripts accepted for publication in the Infection Prevention in Practice Journal, a testament to his skill and dedication in research. Additionally, his consultancy projects have seen him collaborate with leading organizations, such as his role as a field researcher in a study on the efficacy of antivenom. This study, published in PLOS Neglected Tropical Diseases, reflects his dedication to addressing high-impact health issues in Africa.

Beyond publications, Boris has served as a reviewer for prestigious journals, including the American Journal of Public Health. This role reflects his expertise in public health and research rigor, as well as his commitment to advancing the quality and relevance of global health literature. Boris is also an active member of prominent professional bodies, including the American Society of Tropical Medicine and Hygiene, the International Epidemiological Association, and the Cameroon Society of Epidemiology. These memberships further enhance his network, enabling him to share insights and learn from experts worldwide.

Impact and Influence 🌟

Boris’s research and advocacy work has had a far-reaching impact on public health practices, particularly in Cameroon. His research findings have informed policy and operational improvements within the healthcare system, specifically around IPC and emergency care. Through his role with the WHO, he actively trained healthcare workers, elevating IPC standards in response to COVID-19. These training initiatives empowered healthcare personnel to identify and address IPC shortcomings, thus enhancing the safety and effectiveness of healthcare services. His fieldwork and recommendations have laid the groundwork for sustainable public health strategies, contributing to better care outcomes in Cameroon.

In addition, his work on road safety, reflected in his publication on drinking and driving in Cameroon, highlights his dedication to preventive public health measures. This research has implications for traffic safety policies, aligning with his broader goal to improve healthcare and preventative care in all aspects of public life.

Legacy and Future Contributions 🏅

As Boris continues his academic and professional journey, he is committed to leaving a legacy of impactful research and transformative public health practices. His ongoing Ph.D. research, combined with his work as a WHO IPC expert, positions him to make lasting contributions to infection prevention strategies in healthcare settings. He envisions a healthcare system in Cameroon—and by extension, Africa—that is equipped with the knowledge, resources, and frameworks necessary to combat infectious diseases effectively. His research underscores the importance of sustainable IPC practices, a message he aims to reinforce through future publications, presentations, and policy recommendations.

Boris’s goal is not just to influence current practices but to foster a culture of prevention, training, and preparedness in public health systems. His continued contributions to IPC, emergency care, and public health will help build resilient healthcare infrastructures that can withstand future health crises. Through his dedication, Boris aims to empower a new generation of healthcare workers, ensuring that they are equipped with the knowledge and tools necessary to protect communities and save lives.

📝Notable Publications

Title: Roadside surveys of drinking and driving in Cameroon

Authors: Y. Oyono, H. Gjerde, E. Acha Asongalem, B.A. Kouomogne Nteungue, …

Journal: Traffic Injury Prevention

Year: 2021

Title: Prevalence of alcohol among drivers, riders and pedestrians injured in road traffic crashes in Cameroon: a cross-sectional study

Authors: Y. Oyono, H. Gjerde, T. Kelley-Baker, E.A. Asongalem, …

Journal: International Journal of Injury Control and Safety Promotion

Year: 2022